306 related articles for article (PubMed ID: 34188450)
1. Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.
Muhamad Fadzil NS; Sekar M; Gan SH; Bonam SR; Wu YS; Vaijanathappa J; Ravi S; Lum PT; Dhadde SB
Drug Des Devel Ther; 2021; 15():2721-2746. PubMed ID: 34188450
[TBL] [Abstract][Full Text] [Related]
2. Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway.
Pandey T; Shukla A; Trivedi M; Khan F; Pandey R
Bioorg Chem; 2021 Mar; 108():104655. PubMed ID: 33548732
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases.
Leong XY; Thanikachalam PV; Pandey M; Ramamurthy S
Biomed Pharmacother; 2016 Dec; 84():1051-1060. PubMed ID: 27780133
[TBL] [Abstract][Full Text] [Related]
4. A new HPTLC densitometric method for analysis of swertiamarin in Enicostemma littorale and commercial formulations.
Alam P; Ali M; Singh R; Shakeel F
Nat Prod Res; 2011 Jan; 25(1):17-25. PubMed ID: 21240756
[TBL] [Abstract][Full Text] [Related]
5. The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic Effects.
Patel N; Tyagi RK; Tandel N; Garg NK; Soni N
Curr Drug Targets; 2018; 19(16):1958-1967. PubMed ID: 29623834
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking, antiproliferative and anticonvulsant activities of swertiamarin isolated from Enicostemma axillare.
Vaijanathappa J; Puttaswamygowda J; Bevanhalli R; Dixit S; Prabhakaran P
Bioorg Chem; 2020 Jan; 94():103428. PubMed ID: 31740047
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro immunomodulatory potential of swertiamarin isolated from Enicostema axillare (Lam.) A. Raynal that acts as an anti-inflammatory agent.
Saravanan S; Pandikumar P; Prakash Babu N; Hairul Islam VI; Thirugnanasambantham K; Gabriel Paulraj M; Balakrishna K; Ignacimuthu S
Inflammation; 2014 Oct; 37(5):1374-88. PubMed ID: 24736879
[TBL] [Abstract][Full Text] [Related]
8. Chemistry, Biosynthesis, Physicochemical and Biological Properties of Rubiadin: A Promising Natural Anthraquinone for New Drug Discovery and Development.
Watroly MN; Sekar M; Fuloria S; Gan SH; Jeyabalan S; Wu YS; Subramaniyan V; Sathasivam KV; Ravi S; Mat Rani NNI; Lum PT; Vaijanathappa J; Meenakshi DU; Mani S; Fuloria NK
Drug Des Devel Ther; 2021; 15():4527-4549. PubMed ID: 34764636
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of STZ-induced type 1 diabetic nephropathy by aqueous extract of Enicostemma littorale Blume and swertiamarin in rats.
Sonawane RD; Vishwakarma SL; Lakshmi S; Rajani M; Padh H; Goyal RK
Mol Cell Biochem; 2010 Jul; 340(1-2):1-6. PubMed ID: 20229291
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant and hepatoprotective effect of swertiamarin from Enicostemma axillare against D-galactosamine induced acute liver damage in rats.
Jaishree V; Badami S
J Ethnopharmacol; 2010 Jul; 130(1):103-6. PubMed ID: 20420896
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced β-cell damage in Wistar rat pancreas.
Dhanavathy G
J Endocrinol Invest; 2015 Jun; 38(6):669-84. PubMed ID: 25770453
[TBL] [Abstract][Full Text] [Related]
12. Swertiamarin: a lead from Enicostemma littorale Blume. for anti-hyperlipidaemic effect.
Vaidya H; Rajani M; Sudarsanam V; Padh H; Goyal R
Eur J Pharmacol; 2009 Sep; 617(1-3):108-12. PubMed ID: 19577561
[TBL] [Abstract][Full Text] [Related]
13. RP-HPLC analysis of seco-iridoid glycoside swertiamarin from different Swertia species.
Kshirsagar PR; Pai SR; Nimbalkar MS; Gaikwad NB
Nat Prod Res; 2016; 30(7):865-8. PubMed ID: 26299409
[TBL] [Abstract][Full Text] [Related]
14. Rigenolide A, a new secoiridoid glucoside with a cyclobutane skeleton, and three new acylated secoiridoid glucosides from Gentiana rigescens Franch.
Suyama Y; Kurimoto SI; Kawazoe K; Murakami K; Sun HD; Li SL; Takaishi Y; Kashiwada Y
Fitoterapia; 2013 Dec; 91():166-172. PubMed ID: 23994629
[TBL] [Abstract][Full Text] [Related]
15. Effects of Swertia japonica extract and its main compound swertiamarin on gastric emptying and gastrointestinal motility in mice.
Kimura Y; Sumiyoshi M
Fitoterapia; 2011 Sep; 82(6):827-33. PubMed ID: 21571047
[TBL] [Abstract][Full Text] [Related]
16. Iridoid compounds from the aerial parts of
Wang H; Huang H; Lv J; Jiang N; Li Y; Liu X; Zhao H
Nat Prod Res; 2021 May; 35(9):1544-1549. PubMed ID: 33938336
[TBL] [Abstract][Full Text] [Related]
17. Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer-407-induced hyperlipidaemic rats.
Vaidya H; Rajani M; Sudarsanam V; Padh H; Goyal R
J Nat Med; 2009 Oct; 63(4):437-42. PubMed ID: 19633811
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects of Swertiamarin against Methylglyoxal-Induced Epithelial-Mesenchymal Transition by Improving Oxidative Stress in Rat Kidney Epithelial (NRK-52E) Cells.
Parwani K; Patel F; Patel D; Mandal P
Molecules; 2021 May; 26(9):. PubMed ID: 34067107
[TBL] [Abstract][Full Text] [Related]
19. Swertiamarin attenuates inflammation mediators via modulating NF-κB/I κB and JAK2/STAT3 transcription factors in adjuvant induced arthritis.
Saravanan S; Islam VI; Babu NP; Pandikumar P; Thirugnanasambantham K; Chellappandian M; Raj CS; Paulraj MG; Ignacimuthu S
Eur J Pharm Sci; 2014 Jun; 56():70-86. PubMed ID: 24582615
[TBL] [Abstract][Full Text] [Related]
20. Pharmacognosy of Enicostemma littorale: a review.
Saranya R; Thirumalai T; Hemalatha M; Balaji R; David E
Asian Pac J Trop Biomed; 2013 Jan; 3(1):79-84. PubMed ID: 23570022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
